Tetracycline-regulated adeno-associated viral (AAV) vectors...

Chemistry: molecular biology and microbiology – Vector – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S04400A

Reexamination Certificate

active

07811814

ABSTRACT:
A vector and a method are provided for delivering a nucleic acid to a nervous system cell. The vector includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system that includes a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method includes providing a recombinant adeno-associated viral (rAAV) vector and administering the vector to a nervous system cell. Expression of a product from the first nucleic acid is regulatable by the promoter system.

REFERENCES:
patent: 5770414 (1998-06-01), Gage et al.
patent: 5965440 (1999-10-01), Reeves
patent: 6180613 (2001-01-01), Kaplitt et al.
patent: 6503888 (2003-01-01), Kaplitt et al.
patent: 6544780 (2003-04-01), Wang
patent: 6610290 (2003-08-01), Podsakoff et al.
patent: 6875568 (2005-04-01), Nisson et al.
patent: WO 2005/116224 (2005-12-01), None
Baron, U. et al.; “Tet Repressor-Based System for Regulated Gene Expression in Eukaryotic Cells: Principles and Advances;” Methods in Enzymology, vol. 327; 2000; pp. 401-421.
Baron, U. et al.; “Tetracycline-controlled transcription in eukaryotes : novel transactivators with graded transactivation potential;” Nucleic Acids Research; 1997; vol. 25, No. 14; pp. 2723-2729.
Blesch, A. et al.; “Neurite Outgrowth Can Be Modulated In Vitro Using a Tetracycline-Repressible Gene Therapy Vector Expressing Human Nerve Growth Factor;” Journal of Neuroscience Research 59:402-409 (2000).
Connor, B. et al.; “Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat;” Gene Therapy (1999) 6; 1936-1951; 1999.
Corti, O. et al.; “A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors;” Nature Biotechnology, vol. 17; Apr. 1999; pp. 349-354.
Fitzsimons, H.L. et al.; “Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain;” Gene Therapy (2001) 8, 1675-1691.
Gossen, M. et al.; “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters;” Proc. Natl. Acad. Sci. USA; vol. 89; pp. 5547-5551; Jun. 1992; Cell Biology.
Jiang, L. et al.; “Quantitation of Transgene Expression from Self-regulating rAAV Vectors by Flow Cytometry;” American Society of Gene Therapy; Molecular Therapy vol. 5, May 2002, Part 2 of 2 Parts; © The American Society of Gene Therapy, S138; Abstract.
Jiang, L. et al.; “Quantitation of Transgene Expression from Self-regulating rAAV Vectors by Flow Cytometry;” Poster presented at American Society of Gene Therapy meeting on Jun. 6, 2002.
Jiang, L. et al.; “Self regulating rAAV vectors using a tetracycline ( TET )—off promoter are tightly regulated in vitro and in vivo;” Society for Neuroscience Abstract Viewer and Itinerary Planner; vol. 2003, 2003, pp. Abstract No. 79.19; 33rdAnnual Meeting of the Society of Neuroscience: New Orleans, LA, U.S.A.
Jiang, L. et al.; “Tight Regulation from a rAAV Vector as Demonstrated by Flow Cytometry and Quantitative RT-PCR;” Society for Neuroscience Abstract Viewer and Itinerary Planner; vol. 2002, 2002, pp. Abstract No. 902.4; 32ndAnnual Meeting of the Society for Neuroscience; Orlando, Florida, U.S.A.; Nov. 2-7, 2002.
Jiang, L. et al.; “Tight Regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative real-time PCR;” Gene Therapy (2004) 11; pp. 1057-1067.
Kozak, M.; “Structural Features in Eudaryotic mRNAs That Modulate the Initiation of Translation;” The Journal of Biological Chemistry, vol. 266, No. 30, Issue of Oct. 25; pp. 19867-19870; 1991.
Sànchez-Pernaute, R. et al.; “Functional Effect of Adeno-associated Virus Mediated Gene Transfer of AromaticL-Amino Acid Decarboxylase into the Striatum of 6-OHDA-Lesioned Rats;” Molecular Therapy, vol. 4, Issue 4; Oct. 2001; pp. 324-330 (Abstract).
Urlinger, S. et al.; “Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity;”Proc. Natl. Acad. Sci. USA, 97: 7963-7968, 2000.
International Search Report dated Dec. 7, 2005 for International Application No. PCT/US2005/015612.
Berns and Bohenzky, “Adeno-Associated Viruses: An Update”;Advances in Virus Research(Academic Press, Inc.) 32:243-307, 1987.
Bohl et al., “Modulation of Erythropoietin Delivery from Engineered Muscles in Mice”;Hum. Gene Ther., 8:195-204, Jan. 1997.
Chenaud, P. et al.; “Optimal Design of a Single Recombinant Adeno-associated Virus Derived from Serotypes 1 and 2 to Achieve More Tightly Regulated Transgene Expression from Nonhuman Primate Muscle;” Mol. Ther. Mar. 2004; 9(3):410-8.
Choi-Lundberg, D.L. et al.; “Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy”; Science, 275, 838-841, Feb. 7, 1997.
Clark et al.; “Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses;” Hum. Gene Ther., 10: 1031-1039, Apr. 1999.
Eberling, J.L.; “In Vivo PET Imaging of Gene Expression in Parkinsonian Monkeys”;Mol. Ther., 8:873-875, Dec. 2003.
Flotte et al., “Expressions of the Cystic Fibrosis Transmembrane Conductance Regulator from a Novel Adeno-associated Virus Promoter”; J. Biol. Chem., 268: 3781-3790, Feb. 1993.
Gossen, M. et al.; “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters;” Proc. Natl. Acad. Sci. USA; vol. 89; pp. 5547-5551; Jun. 1992; Cell Biology.
Grimm et al., “Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors”;Hum. Gene Ther., 9: 2745-2760, Dec. 1998.
Hasan et al., “Long-Term, Noninvasive Imaging of Regulated Gene Expression in Living Mice”; Genesis, 29: 116-122, 2001.
Kaludov et al., “Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography”; Hum. Gene Ther., 13: 1235-1243, Jul. 2002.
Kozak, M., “Point Mutations Define a Sequence Flanking the AUG Initiator Codon That Modulates Translation by Eukaryotic Ribosomes”; Cell, 44(2):283-92, Jan. 1986.
Kozak, M.; “An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs”; Nucleic Acids Res., Oct. 26;15(20):8125-48, 1987.
Kozak, M.; “Structural Features in Eudaryotic mRNAs That Modulate the Initiation of Translation;” The Journal of Biological Chemistry, vol. 266, No. 30, Issue of Oct. 25; pp. 19867-19870; 1991.
Kozlowski et al., “Quantitative Analysis of Transgene Protein, mRNA, and Vector DNA Following Injection of an Adenoviral Vector Harboring Glial Cell Line-Derived Neurotrophic Factor into the Primate Caudate Nucleus”; Mol. Ther., 3: 256-261, Feb. 2001.
Lo et al., “Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression”; Hum. Gene Ther., 10: 201-213, Jan. 1999.
Muzyczka, “Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells”;Curr Topics Microbiol. Immunol.158:97, 1992.
Peel et al., “Adeno-associated virus vectors: activity and applications in the CNS”; J. Neurosci. Methods, 98:95-104, 2000.
Veldwijk et al., “Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks”; Mol. Ther., 6: 272-278, Aug. 2002.
Xiao et al., “Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Aden

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetracycline-regulated adeno-associated viral (AAV) vectors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetracycline-regulated adeno-associated viral (AAV) vectors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracycline-regulated adeno-associated viral (AAV) vectors... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4163449

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.